Cart
sales@molnova.com
PSB-SB-487
CAS No. 1399049-81-0
PSB-SB-487( —— )
Catalog No. M23554 CAS No. 1399049-81-0
PSB-SB-487 is antagonist of GPR55.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 89 | In Stock |
|
| 5MG | 73 | In Stock |
|
| 10MG | 122 | In Stock |
|
| 25MG | 244 | In Stock |
|
| 50MG | 356 | In Stock |
|
| 100MG | 496 | In Stock |
|
| 200MG | 682 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePSB-SB-487
-
NoteResearch use only, not for human use.
-
Brief DescriptionPSB-SB-487 is antagonist of GPR55.
-
DescriptionPSB-SB-487 is antagonist of GPR55.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorGPR55
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1399049-81-0
-
Formula Weight408.5
-
Molecular FormulaC26H32O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCCCCCCCC(C)(C)C1=CC(=C2C=C(C(=O)OC2=C1)CC3=CC=CC=C3O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Rempel V , Volz N , Gl?Ser F , et al. Antagonists for the orphan G-protein-coupled receptor GPR55 based on a coumarin scaffold.[J]. Journal of Medicinal Chemistry, 2013, 56(11):4798-4810.
molnova catalog
related products
-
A-836339
A-836339 (A836339) is a potent and selective cannabinoid CB2 receptor agonist with Ki of 0.64 and 0.76 nM for human and rat CB2 receptors.
-
CB1 agonist 1
CB1 agonist 1 is a potent CB1 agonist with a pIC50 value of 5.7 for CB1 receptors.CB1 agonist 1 can be used to study brain disorders, pain, and inflammation.
-
Tetrahydrocannabivar...
Tetrahydrocannabivarin is a neutral cannabis receptor subtype (CB1) receptor antagonist, it can increases neural responding to rewarding and aversive stimuli, this effect profile suggests therapeutic activity in obesity, perhaps with a lowered risk of depressive side effects. Tetrahydrocannabivarin exhibits anticonvulsant effects in a piriform cortical brain slice model of epileptiform activity.
